Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability

Neuron

Volumn 25, Issue 2, 2000, Pages 359-371

  Jensen, Kirk B ^a   Dredge, B Kate ^a   Stefani, Giovanni ^a   Zhong, Ru ^a   Buckanovich, Ronald J ^a   Okano, Hirotaka J ^a   Yang, Yolanda Y L ^a   Darnell, Robert B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTIGEN; GLYCINE ALPHA2; MESSENGER RNA PRECURSOR; PROTEIN NOVA 1; RECEPTOR; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATAXIA; BRAIN STEM; CELL SPECIFICITY; CELL VIABILITY; CONTROLLED STUDY; EXON; GENE SEQUENCE; INTRON; MOTOR DYSFUNCTION; MOUSE; MYOCLONUS; NEWBORN; NONHUMAN; OPSOCLONUS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA SPLICING; SPINAL CORD NERVE CELL;

EID: 0033757702     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80900-9     Document Type: Article

References (83)

1. Tumor-specific killer cells in paraneoplastic cerebellar degeneration
2. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration
3. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
4. Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA
5. Regulated splicing of gammα2 pre-messenger RNA in neuronal cells
6. FMR-1 protein: Conserved RNP family domains and selective RNA binding
7. Opsoclonus
8. Sex in flies: The splice of life
9. The inhibitory neuronal glycine receptor
10. Activation of c-src neuron-specific splicing by an unusual RNA element in vivo and in vitro
11. Splicing in the inner ear: A familiar tune, but what are the instruments?
12. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo
13. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system
14. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies
15. Conserved structures and diversity of functions of RNA-binding proteins
16. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors
17. Myoclonus
18. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream
19. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
20. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells
21. 5-HT4 receptors: Cloning and expression of new splice variants
22. Pharmacology and functions of metabotropic glutamate receptors
23. Onconeural antigens and the paraneoplastic neurologic disorders: At the intersection of cancer, immunity and the brain
24. Immunologic complexity in neurons
25. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor
26. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments
27. MER1, a yeast gene required for chromosome pairing and genetic recombination, is induced in meiosis
28. RNA splicing regulates agrin-mediated acetylcholine receptor clustering activity on cultured myotubes
29. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis
30. Absence epilepsy in tottering mutant mice is associated with calcium channel defects
31. Murine chromosomal locations of nine genes encoding homologs of human paraneoplastic neurologic disorder antigens
32. Quantitation of RNA using the polymerase chain reaction
33. Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo
34. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis
35. Splicing regulation in neurons: Tinkering with cell-specific control
36. Common themes in the function of transcription and splicing enhancers
37. Cloned glutamate receptors
38. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor
39. Mechanisms for selecting 5' splice sites in mammalian pre-mRNA splicing
40. Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex
41. Alternative splicing generates two isoforms of the α2 subunit of the inhibitory glycine receptor
42. Sequence-specific RNA binding by a Nova KH-domain: Implications for paraneoplastic disease and the fragile-X syndrome
43. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains
44. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
45. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon
46. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
47. Ethanol, gamma-aminobutyrate type A receptors, and protein kinase C phosphorylation
48. Neuronal pp60c-src contains a six-amino acid insertion relative to its non-neuronal counterpart
49. The K nuclear shuttling domain: A novel signal for nuclear import and nuclear export in the hnRNP K protein
50. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer
51. Neurexins: Three genes and 1001 products
52. Visualizing an olfactory sensory map
53. A hierarchy of Hu RNA binding proteins in developing and adult neurons
54. The cytoplasmic Purkinje antigen cdr2 downregulates Myc function: Implications for neuronal and tumor cell survival
55. mRNA silencing in erythroid differentiation - hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3' end
56. Cytoplasmic regulatory functions of the KH-domain proteins hnRNPs K and E1/E2
57. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation
58. Dopamine D2 receptors in signal transduction and behavior
59. The glycine receptor
60. Brainstem myoclonus
61. A missense mutation in the gene encoding the alpha 1 subunit of the inhibitory glycine receptor in the spasmodic mouse
62. Mouse-musashi-1, a neural RNA binding protein highly enriched in the mammalian CNS stem cell
63. Point mutation of glycine receptor alpha 1 subunit in the spasmodic mouse affects agonist responses
64. Finding a partner in a crowd: Neuronal diversity and synaptogenesis
65. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia
66. Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing
67. Development of glycinergic synaptic transmission to rat brain stem motoneurons
68. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein
69. Flip and flop: A cell-specific functional switch in glutamateoperated channels of the CNS
70. HuD, a paraneoplastic encephalomyelitis antigen contains RNA-binding domains and is homologous to Elav and sex lethal
71. Functions of SR and Trα2 proteins in pre-mRNA splicing regulation
72. Positive control of pre-mRNA splicing in vitro
73. Cartography of neurexins: More than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons
74. The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA
75. Sequential expression and role of Hu RNA-binding proteins during neurogenesis
76. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death
77. Cell- and stage-specific splicing events resolved in specialized neurons of the rat cerebellum
78. A unique intronic splicing enhancer controls the inclusion of the agrin Y exon
79. A striking organization of a large family of human neural cadherin-like cell adhesion genes
80. The neuronal RNA binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia
81. Opioid receptor types and subtypes: The delta receptor as a model
82. Essential nucleotides direct neuron-specific splicing of gamma 2 pre-mRNA
83. Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB